USC’s Keck Medicine in deal to expand local network
Keck Medicine of the University of Southern California completed its acquisition of Orange Coast Oncology Hematology Medical Associates in a move intended to extend the academic medical center’s comprehensive cancer care to more convenient local settings.
“It is estimated we have to send 20% to 25% of our patients elsewhere because we just don’t have the technologies, skills and expertise to deliver what we consider to be the best care locally,” said Dr. Louis Vander-Molen, the newly appointed clinical professor of medicine for Keck and founder of OCOH.
Instead, he said, patients should be able to access cuttingedge clinical therapies, advanced technologies and procedures, consultations with specialists, and research being conducted at the USC Norris Comprehensive Cancer Center and the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC.
Under the terms of the agreement, the OCOH practice becomes part of Keck Medicine of USC and will be known as USC Oncology/Hematology. It will include locations in Newport Beach and Irvine, as well as a treatment center in Newport Beach. Physicians with the former OCOH practice are now also faculty at the Keck School of Medicine and members of USC Care, its medical faculty practice group.